MedTrace Logo

The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases

NCT01867281 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2014-07-01

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of aspirin desensitization on symptoms and immunologic profile of patients with aspirin-exacerbated respiratory diseases (AERD).

Conditions

  • Asthma, Aspirin-Induced

Interventions

DRUG

aspirin

Sponsors & Collaborators

  • Rassoul Akram Hospital

    collaborator OTHER

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Hossein Esmaeilzadeh, MD · Department of Allergy and Immunology, Rasool-e-Akram Hospital, Tehran University of Medical Sciences.

  • Mohammad Nabavi, MD · Department of Allergy and Immunology, Rasool-e-Akram Hospital, Tehran University of Medical Sciences.

  • Zahra Aryan, MD, MPH, student · Molecular Immunology Research Center, Tehran University of Medical Sciences.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01867281 on ClinicalTrials.gov